These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26348216)

  • 1. Releasing the Brakes on Cancer Immunotherapy.
    Ribas A
    N Engl J Med; 2015 Oct; 373(16):1490-2. PubMed ID: 26348216
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer treatment: The killer within.
    Ledford H
    Nature; 2014 Apr; 508(7494):24-6. PubMed ID: 24695297
    [No Abstract]   [Full Text] [Related]  

  • 3. New checkpoint inhibitors ride the immunotherapy tsunami.
    Mullard A
    Nat Rev Drug Discov; 2013 Jul; 12(7):489-92. PubMed ID: 23812256
    [No Abstract]   [Full Text] [Related]  

  • 4. Recruiting T cells in cancer immunotherapy.
    Yost KE; Chang HY; Satpathy AT
    Science; 2021 Apr; 372(6538):130-131. PubMed ID: 33833111
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitors for Urologic Cancer: The Tip of the Iceberg?
    Powles T
    Eur Urol; 2015 Aug; 68(2):280-2. PubMed ID: 25800945
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in cancer immunotherapy].
    Krackhardt AM; Heinrich B
    MMW Fortschr Med; 2017 Aug; 159(14):48-53. PubMed ID: 28924719
    [No Abstract]   [Full Text] [Related]  

  • 7. Promising Immuno-Oncology Treatments Beyond the 2018 Nobel Prize.
    Castelo-Branco L; Silva IP; Canhão H; Awada A
    Acta Med Port; 2019 Apr; 32(4):251-257. PubMed ID: 31067417
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune agonist antibodies face critical test.
    Garber K
    Nat Rev Drug Discov; 2020 Jan; 19(1):3-5. PubMed ID: 31907434
    [No Abstract]   [Full Text] [Related]  

  • 9. Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials.
    Egen JG; Ouyang W; Wu LC
    Immunity; 2020 Jan; 52(1):36-54. PubMed ID: 31940272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy: combine and conquer.
    Nat Med; 2015 May; 21(5):415. PubMed ID: 25951522
    [No Abstract]   [Full Text] [Related]  

  • 11. The immune checkpoint inhibitors: where are we now?
    Webster RM
    Nat Rev Drug Discov; 2014 Dec; 13(12):883-4. PubMed ID: 25345674
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy for bladder cancer: rediscovering an old friend.
    Voskoboynik M; Rudman S; Arkenau HT; Hughes S; Chowdhury S
    BJU Int; 2016 May; 117(5):721-4. PubMed ID: 26389688
    [No Abstract]   [Full Text] [Related]  

  • 13. Breakthrough of the year 2013. Cancer immunotherapy.
    Couzin-Frankel J
    Science; 2013 Dec; 342(6165):1432-3. PubMed ID: 24357284
    [No Abstract]   [Full Text] [Related]  

  • 14. Current and Emerging Perspectives on Immunotherapy for Melanoma.
    Daud A
    Semin Oncol; 2015 Dec; 42 Suppl 3():S3-S11. PubMed ID: 26598057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies.
    Demaria S; Dustin ML
    Immunotherapy; 2013 Feb; 5(2):109-12. PubMed ID: 23413900
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccines versus immunotherapy: overview of approaches in deciding between options.
    Dalgleish AG
    Hum Vaccin Immunother; 2014; 10(11):3369-74. PubMed ID: 25625932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune-checkpoints: the new anti-cancer immunotherapies].
    Ileana E; Champiat S; Soria JC
    Bull Cancer; 2013 Jun; 100(6):601-10. PubMed ID: 23735730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system.
    Pico de Coaña Y; Choudhury A; Kiessling R
    Trends Mol Med; 2015 Aug; 21(8):482-91. PubMed ID: 26091825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promise and challenges of immune agonist antibody development in cancer.
    Mayes PA; Hance KW; Hoos A
    Nat Rev Drug Discov; 2018 Jul; 17(7):509-527. PubMed ID: 29904196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches in cancer immunotherapy -- a light at the end of the tunnel.
    Joshi M; Pal SK; Drabick JJ
    Discov Med; 2016 Jun; 21(118):479-87. PubMed ID: 27448784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.